1. Home
  2. NTLA vs WABC Comparison

NTLA vs WABC Comparison

Compare NTLA & WABC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTLA
  • WABC
  • Stock Information
  • Founded
  • NTLA 2014
  • WABC 1972
  • Country
  • NTLA United States
  • WABC United States
  • Employees
  • NTLA N/A
  • WABC 641
  • Industry
  • NTLA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • WABC Major Banks
  • Sector
  • NTLA Health Care
  • WABC Finance
  • Exchange
  • NTLA Nasdaq
  • WABC Nasdaq
  • Market Cap
  • NTLA 1.4B
  • WABC 1.4B
  • IPO Year
  • NTLA 2016
  • WABC N/A
  • Fundamental
  • Price
  • NTLA $12.18
  • WABC $52.00
  • Analyst Decision
  • NTLA Buy
  • WABC Hold
  • Analyst Count
  • NTLA 17
  • WABC 3
  • Target Price
  • NTLA $56.63
  • WABC $57.00
  • AVG Volume (30 Days)
  • NTLA 2.4M
  • WABC 113.7K
  • Earning Date
  • NTLA 02-20-2025
  • WABC 01-16-2025
  • Dividend Yield
  • NTLA N/A
  • WABC 3.40%
  • EPS Growth
  • NTLA N/A
  • WABC N/A
  • EPS
  • NTLA N/A
  • WABC 5.49
  • Revenue
  • NTLA $43,086,000.00
  • WABC $304,043,000.00
  • Revenue This Year
  • NTLA $52.50
  • WABC N/A
  • Revenue Next Year
  • NTLA $0.42
  • WABC N/A
  • P/E Ratio
  • NTLA N/A
  • WABC $9.43
  • Revenue Growth
  • NTLA N/A
  • WABC N/A
  • 52 Week Low
  • NTLA $11.79
  • WABC $43.82
  • 52 Week High
  • NTLA $34.87
  • WABC $59.97
  • Technical
  • Relative Strength Index (RSI)
  • NTLA 34.42
  • WABC 30.39
  • Support Level
  • NTLA $11.79
  • WABC $55.19
  • Resistance Level
  • NTLA $13.79
  • WABC $56.49
  • Average True Range (ATR)
  • NTLA 0.85
  • WABC 1.43
  • MACD
  • NTLA -0.14
  • WABC -0.78
  • Stochastic Oscillator
  • NTLA 9.97
  • WABC 9.97

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

About WABC Westamerica Bancorporation

Westamerica Bancorp is based in San Rafael, California. Westamerica Bancorporation runs a regional community bank and has approximately $7.5 billion in assets. The banks' net revenue is generated by net interest income. Deposit service charges make up the noninterest income sources. The bank focuses mostly on commercial clients, such as smaller businesses. Its footprint encompasses central and northern California, extending north of San Francisco to Mendocino and Lake counties, south to Kern County in central California, and all the way east to Nevada County.

Share on Social Networks: